Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference
Caribou Biosciences (NASDAQ: CRBU), a clinical-stage CRISPR genome-editing biopharmaceutical company, announced that its President and CEO, Rachel Haurwitz, PhD, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference. The presentation is scheduled for May 13th at 2:35 PM PDT. The webcast will be accessible through Caribou's website and will remain available for at least 30 days following the event.
Caribou Biosciences (NASDAQ: CRBU), un'azienda biofarmaceutica in fase clinica specializzata nell'editing genomico CRISPR, ha annunciato che la sua Presidente e CEO, Rachel Haurwitz, PhD, parteciperà a una discussione informale al BofA Securities 2025 Health Care Conference. La presentazione è prevista per il 13 maggio alle 14:35 PDT. La trasmissione sarà disponibile tramite il sito web di Caribou e resterà accessibile per almeno 30 giorni dopo l'evento.
Caribou Biosciences (NASDAQ: CRBU), una empresa biofarmacéutica en etapa clínica especializada en edición genómica CRISPR, anunció que su presidenta y CEO, Rachel Haurwitz, PhD, participará en una charla informal en la Conferencia de Salud 2025 de BofA Securities. La presentación está programada para el 13 de mayo a las 2:35 PM PDT. La transmisión estará disponible a través del sitio web de Caribou y permanecerá accesible durante al menos 30 días después del evento.
Caribou Biosciences (NASDAQ: CRBU)는 임상 단계의 CRISPR 유전체 편집 바이오제약 회사로, 그 사장 겸 CEO인 Rachel Haurwitz, PhD가 BofA Securities 2025 Health Care Conference에서 화상 토론에 참여할 예정이라고 발표했습니다. 발표는 5월 13일 오후 2시 35분 PDT에 예정되어 있습니다. 웹캐스트는 Caribou 웹사이트를 통해 시청할 수 있으며, 행사 후 최소 30일간 제공됩니다.
Caribou Biosciences (NASDAQ : CRBU), une société biopharmaceutique en phase clinique spécialisée dans l'édition génomique CRISPR, a annoncé que sa présidente et PDG, Rachel Haurwitz, PhD, participera à une discussion informelle lors de la conférence BofA Securities 2025 Health Care. La présentation est prévue pour le 13 mai à 14h35 PDT. Le webcast sera accessible via le site web de Caribou et restera disponible pendant au moins 30 jours après l'événement.
Caribou Biosciences (NASDAQ: CRBU), ein biopharmazeutisches Unternehmen in der klinischen Phase mit Schwerpunkt auf CRISPR-Genom-Editing, gab bekannt, dass seine Präsidentin und CEO, Rachel Haurwitz, PhD, an einem Gespräch beim BofA Securities 2025 Health Care Conference teilnehmen wird. Die Präsentation ist für den 13. Mai um 14:35 Uhr PDT geplant. Das Webcast wird über die Website von Caribou zugänglich sein und mindestens 30 Tage nach der Veranstaltung verfügbar bleiben.
- None.
- None.
BERKELEY, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on May 13th at 2:35 PM PDT.
For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the event.
About Caribou Biosciences, Inc.
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. Caribou is focused on CB-010 and CB-011 as off-the-shelf CAR-T cell therapies that have the potential to provide broad access and rapid treatment for patients with hematologic malignancies. Follow us @CaribouBio and visit www.cariboubio.com.
Caribou Biosciences, Inc. contacts:
Investors:
Amy Figueroa, CFA
investor.relations@cariboubio.com
Media:
Peggy Vorwald, PhD
media@cariboubio.com
FAQ
When is Caribou Biosciences (CRBU) presenting at the BofA Securities Health Care Conference 2025?
Who will represent Caribou Biosciences (CRBU) at the BofA Securities conference?
How long will the CRBU conference webcast be available for viewing?
What type of company is Caribou Biosciences (CRBU)?
